Related Experiment Video
Updated: Aug 6, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Differential toxicity profile of secreted and processed α-Klotho expression over mineral metabolism and bone
Joan Roig-Soriano1, Cristina Sánchez-de-Diego2, Jon Esandi-Jauregui1
1Department of Biochemistry and Molecular Biology, Institut de Neurociènces (INc), Universitat Autònoma Barcelona, Bellaterra, Spain.
Abstract:
The aging-protective gene α-Klotho (KL) produces two main transcripts. The full-length mRNA generates a transmembrane protein that after proteolytic ectodomain shedding can be detected in serum as processed Klotho (p-KL), and a shorter transcript which codes for a putatively secreted protein (s-KL). Both isoforms exhibit potent pleiotropic beneficial properties, although previous reports showed negative side effects on mineral homeostasis after increasing p-KL concentration exogenously. Here, we expressed independently both isoforms using gene transfer vectors, to assess s-KL effects on mineral metabolism. While mice treated with p-KL presented altered expression of several kidney ion channels, as well as altered levels of Pi and Ca2+ in blood, s-KL treated mice had levels comparable to Null-treated control mice. Besides, bone gene expression of Fgf23 showed a fourfold increase after p-KL treatment, effects not observed with the s-KL isoform. Similarly, bone microstructure parameters of p-KL-treated mice were significantly worse than in control animals, while this was not observed for s-KL, which showed an unexpected increase in trabecular thickness and cortical mineral density. As a conclusion, s-KL (but not p-KL) is a safe therapeutic strategy to exploit KL anti-aging protective effects, presenting no apparent negative effects over mineral metabolism and bone microstructure.
Insights
The secreted Klotho (s-KL) protein offers anti-aging benefits without disrupting mineral balance or bone health. Unlike processed Klotho (p-KL), s-KL presents a safe therapeutic strategy for aging protective effects.
Area of Science:
- Gerontology
- Molecular Biology
- Biochemistry
Background:
- The aging-protective gene α-Klotho (KL) has two main transcripts: full-length mRNA producing processed Klotho (p-KL) and a shorter transcript for secreted Klotho (s-KL).
- While KL has beneficial properties, exogenous p-KL administration has shown negative impacts on mineral homeostasis.
Purpose of the Study:
- To investigate the effects of the secreted Klotho (s-KL) isoform on mineral metabolism independently of the processed Klotho (p-KL) isoform.
- To assess the safety and efficacy of s-KL as a therapeutic strategy for anti-aging effects.
Main Methods:
- Independent expression of s-KL and p-KL isoforms using gene transfer vectors in mice.
- Analysis of kidney ion channel expression, blood mineral levels (Pi, Ca2+), and bone gene expression (Fgf23).
- Evaluation of bone microstructure parameters.
Main Results:
- Mice treated with p-KL showed altered kidney ion channel expression and blood mineral levels (Pi, Ca2+), alongside a fourfold increase in bone Fgf23 expression.
- p-KL treatment significantly worsened bone microstructure parameters.
- s-KL treated mice exhibited mineral and bone parameters comparable to control groups, with an unexpected increase in trabecular thickness and cortical mineral density.
Conclusions:
- The secreted Klotho (s-KL) isoform is a safe therapeutic strategy for harnessing KL's anti-aging effects.
- Unlike p-KL, s-KL does not negatively impact mineral metabolism or bone microstructure.
- s-KL demonstrates potential for therapeutic applications without adverse effects on mineral homeostasis and bone health.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling
Skeleton and Calcium Homeostasis
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Osteoclasts in Bone Remodeling

